Proximity of SIV, MLV, and ASLV insertions to oncogenes
. | SIV . | MLV . | ASLV . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6-12 months SIV . | Matching randoms . | P vs randoms . | 35-47 months SIV . | Matching randoms . | P vs randoms . | All SIV . | Matching randoms . | P vs randoms . | All MLV . | Matching randoms . | P vs randoms . | All ASLV . | Matching randoms . | P vs randoms . | |
Total mapped integrations | 289 | 267 | 519 | 396 | 198 | ||||||||||
No. of integrations within 30 kb of 1 or more oncogenes* | 13 | 4.29 | < .001 | 15 | 3.96 | < .001 | 26 | 7.69 | < .001 | 16 | 5.66 | < .001 | 2 | 3.14 | .392 |
No. of integrations within 30 kb of 1 or more genes† | 272 | 152 | < .001 | 252 | 140 | < .001 | 490 | 273 | < .001 | 304 | 202 | < .001 | 137 | 107 | < .001 |
% of sites (within 30 kb of gene) that are within 30 kb of oncogene | 4.8% | 2.8% | .084 | 5.9% | 2.8% | .022 | 5.3% | 2.8% | .014 | 5.3% | 2.8% | .028 | 1.5% | 2.9% | .178 |
. | SIV . | MLV . | ASLV . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6-12 months SIV . | Matching randoms . | P vs randoms . | 35-47 months SIV . | Matching randoms . | P vs randoms . | All SIV . | Matching randoms . | P vs randoms . | All MLV . | Matching randoms . | P vs randoms . | All ASLV . | Matching randoms . | P vs randoms . | |
Total mapped integrations | 289 | 267 | 519 | 396 | 198 | ||||||||||
No. of integrations within 30 kb of 1 or more oncogenes* | 13 | 4.29 | < .001 | 15 | 3.96 | < .001 | 26 | 7.69 | < .001 | 16 | 5.66 | < .001 | 2 | 3.14 | .392 |
No. of integrations within 30 kb of 1 or more genes† | 272 | 152 | < .001 | 252 | 140 | < .001 | 490 | 273 | < .001 | 304 | 202 | < .001 | 137 | 107 | < .001 |
% of sites (within 30 kb of gene) that are within 30 kb of oncogene | 4.8% | 2.8% | .084 | 5.9% | 2.8% | .022 | 5.3% | 2.8% | .014 | 5.3% | 2.8% | .028 | 1.5% | 2.9% | .178 |